Kenny John P.

Chief Executive Officer, DirectorMERIDIAN BIOSCIENCE INC (VIVO) · full profile →Form 4 · filed Jun 24, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2022Sell(S)20K$29.98265K
Jun 23, 2022Option exercise(M)15K$10.10$148K285K
Jun 23, 2022Option exercise(M)5K$14.50$78K270K
Jun 22, 2022Option exercise(M)45K$14.50$647K310K
Jun 22, 2022Sell(S)45K$29.72265K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 23, 2022Option exercise(M)5K$00
Jun 23, 2022Option exercise(M)15K$0141K
Jun 22, 2022Option exercise(M)45K$05K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-22-018097) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about VIVO insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001127602-22-018097"
Ask your agent
Use Arkolith to summarize insider buying and selling at MERIDIAN BIOSCIENCE INC
over the last 90 days and cite the filings.